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Ventricular tachycardia (VT) occurring in patients who have had aprevious myocardial infarction has been demonstrated to be dueto reentry. Critical components of this reentrant circuit—withoutwhich the tachycardia cannot continue—have been shown to belocated within endocardial or subendocardial layers of the infarctzone or its periphery. This is fortunate, in that it allows a sur-
geon’s knife or an electrophysiologist’s catheter to have access to critical compo-
nents of the VT circuit to incise, remove, or ablate this relatively small amount of
tissue and thereby eliminate VT recurrences. In hearts that have already sustained
muscle loss from infarction, it stands to reason that one should attempt to minimize
the amount of additional damage done to eradicate the tissue responsible for VT.
The process of electrophysiologic mapping has been a mainstay of surgical therapy
for VT in that it attempts to localize these critical areas of the reentrant circuit, such
that minimal incision, resection, or ablation could effect antiarrhythmic success. The
more complete the mapping data, the better the arrhythmia cure rate.1 However, in
practice, mapping has several limitations (some of which are discussed herein), and
because one cannot always be certain that all arrhythmogenic areas have been
identified, most surgeons use a generous resection or cryoablation margin beyond
areas indicated by mapping—even to the point of removing all visible endocardial
scar.2
Standard VT Mapping and Return Cycle Mapping
During standard VT mapping, one attempts to locate areas of the endocardium from
which diastolic potentials (timing between the end of one VT QRS and the next) are
recorded. The central common pathway (CCP) of the VT circuit should be in such
an area, although diseased tissue in other areas may masquerade as CCP by having
similar diastolic timing. These areas of greatest interest are anatomically small (2-4
cm2), and recordings from them have very low amplitudes and great complexity,
making their interpretation difficult. Nitta and associates3 have attempted to cir-
cumvent these problems with return cycle mapping. With this technique, one uses
a short burst of overdrive pacing during VT (“entrainment”) and records the timing
of activation of large areas of endocardium during the first 2 beats of VT when it
resumes after cessation of pacing. An isochronal line connecting recording sites at
which the length of the return cycle equals the VT cycle length can be plotted. When
pacing is performed at several different sites, a family of such isochrones is made;
Nitta’s group found that the point of intersection of these lines is at the CCP.
Is the return cycle mapping technique valid? It seems to reliably point to the
entrance to the CCP. Nitta and colleagues3 have taken the necessary steps to validate
the technique by terminating VT with cryoablation at sites to which they were
directed by the return cycle mapping method. If the technique is so good, are there
any limitations to its use? As it turns out, quite a few conditions have to be met
before return cycle mapping can be applied successfully to yield its impressive
results. Many of these apply to standard mapping as well.
1. Sustained uniform VT must be inducible during surgery. In at least 10% of
cases, VT cannot be induced and its occurrence cannot be predicted before the
procedure. Without sustained VT, return cycle mapping cannot be applied at
all.
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2. VT must be entrainable; that is, overdrive pacing
during VT must capture the heart and the same VT
resume after pacing ceases. If VT terminates after
pacing or changes to a different morphology, return
cycle mapping cannot be used.
3. A large number of simultaneously recording elec-
trodes must be in the heart, some of which must
overlie the region of the CCP, to form the necessary
family of isochrones for return cycle mapping. This
requires specialized equipment that is not available at
all centers.
4. It must be possible to pace and capture at multiple
sites, once again to form the set of isochrones whose
intersection is at the CCP.
5. Finally, not all forms of reentry have a CCP, and the
usefulness of return cycle mapping in such cases is
unclear.
Return cycle mapping has not yet been evaluated in man;
however, if the technique is validated in human VT map-
ping and ablation, it could prove useful as an additional tool.
If a team of surgeons and electrophysiologists then plans to
use return cycle mapping to cure a patient of VT, they can
probably anticipate a good result if all the aforementioned
conditions are met. However, they should also have contin-
gency plans if any one condition fails. Alternate techniques
include mapping areas of fragmented electrograms during
sinus rhythm if VT cannot be initiated4 or using standard
activation mapping techniques if overdrive pacing for return
cycle mapping results in VT termination or change in VT
morphology.
The Big Picture
Regardless of how useful return cycle mapping may be, a
larger question remains: Is it needed? This is very much in
doubt, because very few direct surgical procedures are per-
formed currently. This is not for lack of good mapping
techniques, but because alternatives exist. These include the
implantable cardioverter-defibrillator (ICD) and catheter ab-
lation for VT. In particular, the ICD has largely supplanted
surgical ablation for therapy of VT by virtue of its superior
peri-procedural morbidity and mortality, high efficacy and
reliability, and ease of use. In cases of frequent VT epi-
sodes, catheter ablation (especially combined with ICD
therapy) provides very good palliation or even cure.5,6 There
are still circumstances in which neither of these therapies is
reasonable and mapping-directed therapy for VT is prefer-
able.7,8 These include very frequent or incessant, hemody-
namically poorly tolerated VT, known left ventricular
thrombus (precluding catheter ablation), patient preference
(potential for surgical cure rather than palliation), and the
need for concomitant revascularization or valve surgery.
On this last point, most authorities believe that intraop-
erative VT mapping and ablation adds significant time and
perhaps morbidity to the procedure.7,9,10 This concern raises
the question of whether patients who have known risk
factors for VT (prior infarction, especially with a left ven-
tricular aneurysm) and are undergoing revascularization or
valve surgery should have concomitant attempts at VT
mapping and ablation or whether they should simply have
an ICD inserted. In patients who have had preoperative
spontaneous episodes of VT (and perhaps even syncope,
which may have been caused by VT), concomitant arrhyth-
mia surgery is usually warranted to prevent very frequent
VT recurrences in the postoperative period.11 Because such
cases are infrequent, once identified they should probably be
referred to a center that maintains the required equipment
and expertise to provide the best possible environment for
surgery. In patients who have not yet had spontaneous
arrhythmia episodes, the answer is less certain. Preoperative
electrophysiologic study may clarify this, if it can be per-
formed safely.12 Further complicating the decision is the
fact that, for most surgical endocardial mapping and abla-
tion techniques, an open ventricle is necessary—and, along
with it, cardiopulmonary bypass. With increasingly frequent
use of off-pump and minimally invasive revascularization
techniques, adding an open-ventricle procedure negates the
advantages of these techniques.
If return cycle mapping has missed its chance to make a
major difference in surgical therapy of VT, perhaps it will
have substantial application in endocardial catheter map-
ping of both ventricular and atrial macroreentrant arrhyth-
mias (such as those occurring after atriotomy for septal
defect or atrioventricular valve repair). Return cycle map-
ping could be used in conjunction with multipolar mapping
systems such as noncontact arrays or basket contact cathe-
ters to localize the entrance to CCPs of these arrhyth-
mias.13,14 To our knowledge, this technique has not yet been
applied in these situations.
It is unlikely that return cycle mapping—or any mapping
technique, for that matter—will ever replace the ICD for
treatment of VT.8 If anything, ICD therapy is becoming
more appealing because of the continued decrease in device
size and increase in battery life, ease of implantation, reli-
ability, and feature set. Surgery, on the other hand, contin-
ues to have a moderate operative morbidity and mortality
and is not uniformly successful. In carefully selected cas-
es,7,9 however, intraoperative mapping—perhaps with re-
turn cycle mapping—and surgical therapy can provide a
very good outcome. Thus, although this new technique may
not result in therapy for VT coming “full cycle” and return-
ing to its origins in the operating room, it nonetheless offers
new insights and options, which are always good to have.
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